Blocking of integrin-mediated human MV3 melanoma cell binding by commercial and modified heparins.
Schlesinger
M
M
Department of Pharmacy, University Bonn, Bonn, Germany.
Naggi
A
A
Torri
G
G
Zeisig
R
R
Alexander
M
M
Schmitz
P
P
Casu
B
B
Bendas
G
G
D002448:Cell Adhesion / Q000187:drug effects; D045744:Cell Line, Tumor; D006493:Heparin / Q000031:analogs & derivatives / Q000494:pharmacology*; D006801:Humans; D039041:Integrin alpha4beta1 / Q000037:antagonists & inhibitors / Q000502:physiology*; D008545:Melanoma / Q000473:pathology / Q000556:secondary*; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism
D039041:Integrin alpha4beta1; D019010:Vascular Cell Adhesion Molecule-1; D006493:Heparin